Jonathan Krinsky, chief market technician at BTIG, joins CNBC's 'The Exchange to discuss his outlook on stocks for 2025, what ...

BTIG lowered the firm’s price target on Staar Surgical (STAA) to $39 from $49 and keeps a Buy rating on the shares as part of a broader ...

BTIG analyst Ryan Zimmerman maintained a Buy rating on Staar Surgical (STAA – Research Report) today and set a price target of $39.00. The ...

BTIG Research has recently reduced FiscalNote Holdings Inc (NOTE) stock to Neutral rating, as announced on November 15, 2023, according to Finviz. Earlier, on July 26, 2023, B. Riley Securities had ...

FREYR Battery Inc (FREY) stock saw a decline, ending the day at $2.58 which represents a decrease of $-0.12 or -4.44% from the prior close of $2.7. The stock opened at $2.71 and touched a low of $2.45 ...

BTIG analysts initiated coverage of SunCar Tech Group (NASDAQ:SDA) with a Buy rating and a $12 price target, highlighting the ...

Analyst initiates coverage on cloud-based auto services provider SunCar Technology (SDA) with Buy rating, projecting 25% annualized growth.

Jonathan Krinsky, BTIG chief market technician, joins 'Closing Bell' to discuss why he's cautious on Apple and the market ...

https://www.tipranks.com/news/the-fly/streamline-health-expands-presence-in-texas-with-400-bed-health-system BTIG analyst Julian Harrison initiated coverage of Avalo ...

Adaptive Biotechnologies (NASDAQ:ADPT – Get Free Report) had its price objective lifted by stock analysts at BTIG Research from $8.00 to $9.00 in a report released on Wednesday,Benzinga reports.

On Thursday, BTIG initiated coverage on Cartesian Therapeutics, trading on NASDAQ:RNAC, with a positive outlook, assigning a Buy rating and a price target of $42.00. The stock, currently trading at ...

On Wednesday, Real Brokerage Inc. (NASDAQ:REAX) was given a positive outlook by BTIG, as the firm started coverage on the company's stock with a Buy rating and a price target of $6.00. The firm ...